Monoclonal Proteins
| Accreditation Status: | UKAS Schedule of Accreditation | ||||||||||
| Date Scheme started: | 1993 | ||||||||||
| Clinical Applicability: | Diagnosis of monoclonal gammopathy in serum and urine | ||||||||||
| Analytes: | Total serum protein, Albumin, IgG, IgA, IgM, serum free light chains (Kappa, Lambda and ratio), urine total protein & Monoclonal Component identification and Quantitation (SER/019) | ||||||||||
| Units for Reporting: | Isotype of heavy and light chain together with the concentration of monoclonal protein in g/L. Serum free light chains in mg/L. | ||||||||||
| Samples Distributed: |
Liquid format. Normal and pathological human serum and urine Each distribution will contain a serum sample and a urine sample; they should be considered as separate requests for investigation. It should NOT BE ASSUMED that they emanate from the same patient. |
||||||||||
| Number of Distributions per year: | 6 | ||||||||||
| Number of Samples per Distribution: | 2 (1 urine and 1 serum) | ||||||||||
| Frequency of Distributions: | Every two months as outlined in the Distribution Schedule | ||||||||||
| Schedule of Analysis: | Data entry is via the web for the submission of results. Data analysis commences 21 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics. | ||||||||||
| Data Analysis: |
Whilst the programme will analyse participant's isotype identification and monoclone quantitation, the returns will require data on total serum protein, albumin, IgG, IgA, IgM (and urine total protein). The latter information will not be formally analysed as it is covered in other EQA programmes but will be of value in the recognition of analytical or isotype identification problems. Chosen Coefficient of Variation: 14% for Serum Monoclonal Component Quantitation. Chosen Coefficient of Variation: 29% for Serum free light chain Quantitation. Chosen Coefficient of Variation: 20% for Bence Jones Protein Quantitation. |
||||||||||
| Performance Scoring: |
MI Scoring - The qualitative elements of electrophoresis, isotype and free light chains identification. MRVIS - Assessment of the monoclone quantitation and free light chains. |
||||||||||
| Criteria of Performance: |
The qualitative elements of electrophoresis and isotype identification are assessed by MIscoring over a running analytical window of 6 Distributions (12 months)
|
||||||||||
| Poor Performance |
For the monoclonal component and serum Free Light Chain quantitation, laboratory performance is assessed in relation to the MRVIS over a running analytical window of 6 Distributions.
|
||||||||||
| Persistent Poor Performance: |
Defined as being in the Poor Performance category for two or more successive Distributions |
